Prof. Dr. Sven Thoms studied chemistry and biochemistry in Konstanz, Brighton, and Witten and worked with Stefan Jentsch at the ZMBH in Heidelberg and at the Friedrich Miescher Labor of the Max-Planck Society in Tübingen. Triggered by a remark by Stefan Jentsch, he fell in love with peroxisomes and has been fortunate enough to be able to work on peroxisomes ever since, throughout his Postdoc in Bochum, and as a group leader at the Department for Pediatrics in Göttingen. In 2020, he was called to a professorship of Biochemistry and Molecular Medicine at the newly established Medical School EWL and became its first research dean (2021-2022). Research interests of the lab include peroxisomes, dysferlin, and translational readthrough.
I am the team assistant of the AG and take care of the bureaucracy. I try to keep my colleagues' backs free so that they can concentrate on research.
I studied Molecular Medicine in Göttingen and conducted my PhD working on Dysferlin and investigating its cellular and molecular function in skeletal and heart muscle. I analyzed functional translational readthrough of malate dehydrogenase and the re-interpretation of the genetic code by functional translational readthrough. Since 2016, I have worked in SFB1002 on the 'Role of peroxisomes in heart metabolism and heart failure'.
After I studied Human Biology and Tumor Biology in Marburg and Freiburg, I joined the Biochemistry and Molecular Medicine department as a Post-Doc in June 2021. My research focuses on Molecular Cell Biology in the context of Rare Diseases and aims to understand processes within a cell by analyzing the behavior of individual proteins and their contribution towards phenotypes at the physiological level.
Manar is an expert in clinical and molecular cardiology. She holds two doctorates, an MD and a PhD.
I completed my PhD in Physics at Bielefeld University, where my research was centered on advancing methods and applications within the fields of super-resolution fluorescence microscopy and ion conductance microscopy. Following this, I became part of the Biomolecular Photonics group, where I developed the nanoinjection technology for single-cell manipulation. Subsequently, working at the Institute for Biophysical Chemistry at Hannover Medical School, my research focus switched to biochemistry, working on actin-based force generation processes in cells. Since April 2024, I have joined the Biochemistry and Molecular Medicine group to further my research interests.
After completing my Master’s degree in Immunobiology at the University of Bonn and Dalhousie University, Canada, I joined the BCMM as a PhD student in April 2022. In my PhD project, I am investigating the role of peroxisomes in cellular energy and calcium homeostasis.
I completed my Master's degree in Interdisciplinary Biomedicine in Bielefeld and started my PhD in BCMM in June 2021. I am working on the role of peroxisomes in the heart and in particular their contribution to heart failure as part of the SFB1002.
I studied Molecular Biology in Bielefeld and Interdisciplinary Biomedicine in the Master's program. From February 2023, I will be investigating the biogenesis of peroxisomes as part of my PhD.
I completed my master's degree in Molecular Cell Biology at Bielefeld University. My research during my master's thesis focused on the critical positions in the stop codon context and examined differences in translational readthrough. I have been pursuing my doctoral thesis since December 2023 in the BCMM group, driven by a strong interest in elucidating the underlying mechanisms. I look forward to continuing this journey and contributing to unraveling the world of molecular cell biology.
I studied Biochemistry with a focus on cellular functions in Bielefeld and joined the BCMM group as a PhD student in February 2022. Since then, my interest in the interplay of different organelles and factors involved in peroxisomal biogenesis has grown and I intend to understand the contributing molecular mechanisms.
In 2021, I finished my Master’s degree in Molecular Cell Biology in Bielefeld. Afterwards, I started my PhD thesis in the BCMM group in May 2021, studying translational readthrough. I am particularly interested in molecular mechanisms that impact the efficiency of readthrough, in its use as a potential therapeutic strategy, and in proteins acquire new functions after translational readthrough through a C-terminal extension.
I completed my Master's degree in Biochemistry with a focus on structure and function of biological macromolecules at Bielefeld University. Since July 2021 I am working as a PhD student in the BCMM team. In my PhD I am investigating the tail-anchor protein dysferlin, with a focus on structural and functional characterization.